Symposium Speaker: Aniwaa Owusu Obeng, PharmD

Aniwaa Owusu Obeng, PharmD, is Assistant Professor of General Internal Medicine and Clinical Pharmacogenomics Coordinator at the Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai in New York.  Dr. Obeng is also currently adjunct experiential faculty with Albany College of Pharmacy and Health Sciences and Long Island University Arnold and Marie Schwartz College of Pharmacy.  Dr. Obeng earned her doctorate of pharmacy from Albany College of Pharmacy and Health Sciences in 2011 followed by residencies at the Bronx Lebanon Hospital Center and the University of Florida, the latter as the inaugural resident for the UF Pharmacogenomics Pharmacy Residency (PGY2) program At Mount Sinai, Dr. Obeng's current research interests include translational pharmacogenomics, and she is active is several relevant consortia including the electronic MEdical Records & GEnomics (eMERGE) network, the Implementing GeNomics In pracTicE (IGNITE), and Clinical Pharmacogenomics Implementation Consortium (CPIC), among others.

 

Recent Publications

  1. Duarte, JD, Dalton, R, Elchynski, AL, Smith, DM, Cicali, EJ, Lee, JC, Duong, BQ, Petry, NJ, Aquilante, CL, Beitelshees, AL et al.. Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing. Genet Med 2021; 23 (12): 2335-2341. PubMed PMID:34282303 .
  2. Eric, V, Yi, V, Murdock, D, Kalla, SE, Wu, TJ, Sabo, A, Li, S, Meng, Q, Tian, X, Murugan, M et al.. Neptune: an environment for the delivery of genomic medicine. Genet Med 2021; 23 (10): 1838-1846. PubMed PMID:34257418 PubMed Central PMC8487966.
  3. Liu, M, Obeng, AO. Siponimod and CYP2C9 Allele Prevalence Among Blacks. J Clin Pharmacol 2020; 60 (4): 429-431. PubMed PMID:31701536 .
  4. eMERGE Consortium. Electronic address: agibbs@bcm.edu, eMERGE Consortium. Harmonizing Clinical Sequencing and Interpretation for the eMERGE III Network. Am J Hum Genet 2019; 105 (3): 588-605. PubMed PMID:31447099 PubMed Central PMC6731372.
  5. Coriolan, S, Arikawe, N, Moscati, A, Zhou, L, Dym, S, Donmez, S, Garba, A, Falbaum, S, Loewy, Z, Lull, M et al.. Pharmacy students' attitudes and perceptions toward pharmacogenomics education. Am J Health Syst Pharm 2019; 76 (11): 836-845. PubMed PMID:31415690 PubMed Central PMC6523044.
  6. Cavallari, LH, Van Driest, SL, Prows, CA, Bishop, JR, Limdi, NA, Pratt, VM, Ramsey, LB, Smith, DM, Tuteja, S, Duong, BQ et al.. Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing. Genet Med 2019; 21 (10): 2255-2263. PubMed PMID:30894703 PubMed Central PMC6754805.
  7. Hauser, D, Obeng, AO, Fei, K, Ramos, MA, Horowitz, CR. Views Of Primary Care Providers On Testing Patients For Genetic Risks For Common Chronic Diseases. Health Aff (Millwood) 2018; 37 (5): 793-800. PubMed PMID:29733703 PubMed Central PMC6503526.
  8. Rasmussen-Torvik, LJ, Almoguera, B, Doheny, KF, Freimuth, RR, Gordon, AS, Hakonarson, H, Hawkins, JB, Husami, A, Ivacic, LC, Kullo, IJ et al.. Concordance between Research Sequencing and Clinical Pharmacogenetic Genotyping in the eMERGE-PGx Study. J Mol Diagn 2017; 19 (4): 561-566. PubMed PMID:28502727 PubMed Central PMC5500823.
  9. Cavallari, LH, Beitelshees, AL, Blake, KV, Dressler, LG, Duarte, JD, Elsey, A, Eichmeyer, JN, Empey, PE, Franciosi, JP, Hicks, JK et al.. The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting. Clin Transl Sci 2017; 10 (3): 143-146. PubMed PMID:28294551 PubMed Central PMC5421730.
  10. Moriyama, B, Obeng, AO, Barbarino, J, Penzak, SR, Henning, SA, Scott, SA, Agúndez, J, Wingard, JR, McLeod, HL, Klein, TE et al.. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy. Clin Pharmacol Ther 2017; 102 (1): 45-51. PubMed PMID:27981572 PubMed Central PMC5474211.
Search PubMed

The Obeng Lab Website

Curriculum vitae